CENTG3 (AGAP3) (NM_031946) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC212440L4V
- LentiORF®
-
Lenti ORF particles, AGAP3 (mGFP-tagged) - Human ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 (AGAP3), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 18,050.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | CENTG3 (AGAP3) (NM_031946) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | AGAP-3; CENTG3; cnt-g3; CRAG; MRIP-1 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_031946 |
ORF Size | 2733 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC212440).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_031946.4 |
RefSeq Size | 3247 bp |
RefSeq ORF | 2736 bp |
Locus ID | 116988 |
Domains | ArfGap, PH, ANK, RAS, RAB |
MW | 97.8 kDa |
Gene Summary | This gene encodes an essential component of the N-methyl-D-aspartate (NMDA) receptor signaling complex which mediates long-term potentiation in synapses by linking activation of NMDA receptor to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking. The encoded protein contains an N-terminal GTPase-like domain, a pleckstrin homology domain, an ArfGAP domain and several C-terminal ankryn repeat domains. [provided by RefSeq, Apr 2017] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...